Organized by the Biotechnology Innovation Organization (BIO), the BIO International Convention is widely recognized as the most comprehensive event in the biotechnology industry. Each year, it attracts more than 20,000 industry leaders from around the world, including executives, researchers, investors, policymakers, and entrepreneurs.

The convention covers the full biotechnology ecosystem—from pharmaceutical development and genomics to agricultural biotech, digital health, and biomanufacturing. Participants attend high-level keynote presentations, educational sessions, and industry panels that highlight emerging trends and scientific advancements across the life sciences sector.

A central feature of the event is the BIO Exhibition and Business Forum, where companies present innovative technologies, research tools, and therapeutic platforms while thousands of partnering meetings take place between biotech firms, pharmaceutical companies, investors, and research institutions. These meetings are critical for forming partnerships, licensing deals, and strategic collaborations that drive new therapies and innovations.

With its focus on discovery, collaboration, and commercialization, the BIO Convention serves as a global hub for the biotech community to connect and accelerate life-science innovation.